Vetter welcomes the State Minister for Economics, Labor, and Housing

State Minister Dr. Nicole Hoffmeister-Kraut (second from the left) is being shown around the Ravensburg Vetter production site to explain the high standards required for qualitative medication manufacturing. In the picture (l to r): Senator h. c. Udo J. Vetter, Chairman of the company's advisory board and member of the owner family, Dr. Nicole Hoffmeister-Kraut, Baden-Württemberg State Minister for Economics, Labor, and Housing, Harald Sievers, District Administrator of Ravensburg County, and Vetter Managing Director Thomas Otto. (Image source: Vetter Pharma International GmbH)

- Exchange on challenges in the region and industry
- Tour of the state-of-the-art production site Ravensburg Vetter Süd
- Presentation of central digitalization and innovation initiatives of the pharmaceutical service provider

High-level visit to Vetter, a partner of global pharmaceutical companies for the production of some life-saving medications: Dr. Nicole Hoffmeister-Kraut, Baden-Württemberg's Minister for Economic Affairs, Labour and Housing, was on-site today at the family-owned company in Ravensburg. She exchanged views with the management of the pharmaceutical service provider and political representatives about the challenges faced by medium-sized companies in the region, as well as innovations and the state of digitalization in the pharmaceutical industry. Another highlight of the visit was a tour of the Ravensburg Vetter Süd production site, which is among the most modern pharmaceutical manufacturing facilities in the world.

"As one of the largest employers in the Lake Constance-Upper Swabia region, Vetter is an important player in Baden-Württemberg's economy," explained Dr. Nicole Hoffmeister-Kraut. "At the same time, its success story from a pharmacy to a global market leader is exemplary for many medium-sized companies: it shows what can be achieved with openness to innovation and bold, future-oriented decisions — also in view of current challenges such as digitalization."

"The visit of Minister Dr. Hoffmeister-Kraut is a special honor and at the same time a confirmation of our consistent corporate development: As a partner of large and small pharmaceutical and biotech companies, we make an important contribution to patient treatment worldwide," said Senator h. c. Udo J. Vetter, Chairman of the Supervisory Board of the company and member of the founding family. "That is why we continuously invest in technology, process, and service innovations. Digitalization, as an important driver of innovation, plays a decisive role," added Managing Director Thomas Otto.

As part of the visit, Vetter reported on specific digitalization initiatives within the company: The pharmaceutical service provider recognized early on the technological opportunities and is therefore working company-wide on the implementation of numerous digitalization projects. Employees are encouraged to participate in all processes and thus significantly shape Vetter's digital future.

The company's innovation management was also on the agenda of the visit: Various events and formats contribute to the generation and implementation of innovative ideas. For example, employees can directly try out novel ideas that are currently undergoing the company's internal innovation process during the Hands on Innovation Day and get to know them at an early stage. In the Vetter Open Innovation Challenge – Injection 2.0, multidisciplinary teams developed new approaches last year on how digital developments can be profitably integrated into patient treatment.

Participants received practical insights into the various initiatives of the pharmaceutical service provider during the visit. Together with its customers from the pharmaceutical and biotech industries, Vetter aims to improve the quality of life for patients worldwide.